Ancora Biotech

Palo Alto, United States

Ancora Biotech is a privately held company supporting the clinical development of three multi-specific antibodies.

$60.0M raised

Jun 2022

Series A

Biotechnology Health Care Wellness

Top Investors

Lightspeed Venture Partners SR One

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Ancora Biotech

How much funding has Ancora Biotech raised?

Ancora Biotech has raised $60.0M in total funding. The most recent round was Series A. The last funding was announced in June 2022.

Who are Ancora Biotech's investors?

Ancora Biotech's investors include Lightspeed Venture Partners, SR One.

Where is Ancora Biotech headquartered?

Ancora Biotech is headquartered in Palo Alto, United States.

What does Ancora Biotech do?

Ancora Biotech is a privately held company supporting the clinical development of three multi-specific antibodies.

What stage is Ancora Biotech at?

Ancora Biotech is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 9, 2022.

MLA

"Ancora Biotech — Funding & Investors." VCBacked, June 9, 2022, https://www.vcbacked.co/company/ancora-biotech. Accessed July 2, 2026.

APA

VCBacked. (2022). Ancora Biotech — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/ancora-biotech

Wikipedia (cite web)

{{cite web |title=Ancora Biotech — Funding & Investors |url=https://www.vcbacked.co/company/ancora-biotech |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 9, 2022.

Similar Companies in Biotechnology

View all

Rapport Therapeutics

Boston$250.0M

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K